Efficacy of Duloxetine for VIPN (Vincristine-Induced Peripheral Neuropathy) Treatment

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2015
INTERVENTION: Duloxetine Placebo CONDITION: Non‐Hodgkin lymphoma PRIMARY OUTCOME: Reduction of average pain after administration of duloxetine INCLUSION CRITERIA: have a symptom of VIPN after administration of (R‐)CHOP/(R‐)CVP for Non‐Hodgkin lymphoma
Epistemonikos ID: 0892e469a38897f18ae2ef846e5014b2a183f36d
First added on: Aug 24, 2024